EZH2 and esophageal squamous cell carcinoma: Moreover, although CYH33 treatment for 24 h significantly inhibited the phosphorylation of RB in EV32 cells, this effect failed to be achieved in HE6 cells, suggesting that the overexpression of EZH2 maintained active cell cycle progression in ESCC cells.